1-855-416-7738 info@preveceutical.com
CSE: PREV OTC: PRVCF FSE: 18H

Investor Information

To expand Press Releases and Media sections click on the "+" button and to collapse click on the "-" button.

Press Releases
PreveCeutical – Begins Trading on the OTC Market – August 16, 2017

PreveCeutical – Requisitions to Acquire Instrumentation Expediting R&D Programs – August 14, 2017

PreveCeutical – Preliminary Results from Phase One of Venom Re-Engineering Project – August 11, 2017

PreveCeutical – Letter of Intent Signed with UniQuest Pty Limited – August 8, 2017

PreveCeutical – Begins Trading on the Frankfurt Stock Exchange – August 1, 2017

PreveCeutical – Launches Phase One of Venom Re-Engineering Project – July 25, 2017

PreveCeutical – Signs Research and Option Agreement with UniQuest – July 17, 2017

PreveCeutical – Closing of Reverse Take-Over Transaction – July 10, 2017

PreveCeutical – Carrara Receives Acquisition Acceptance – June 21, 2017

PreveCeutical – Harendra Parekh Appointed Chief Research Officer – May 17, 2017

PreveCeutical – R&D Agreement Signed with UniQuest for CBD Formulations – April 24, 2017

PreveCeutical – R&D Agreement Signed With UniQuest Pty Limited – April 20, 2017

PreveCeutical – Letter of Intent Signed with UniQuest Pty Limited – April 13, 2017

PreveCeutical – Investor Presentation & Private Placement Financing – March 29, 2017

PreveCeutical – Carrara & PreveCetuical Sign Amalgamation Agreement – March 22, 2017

PreveCeutical – Carrara Signs Acquisition Letter of Intent – February 17, 2017

PreveCeutical – Closing of Debt Financing – January 12, 2016

PreveCeutical – Scorpion Venom: Assists in Health & Wellness – December 20, 2016

PreveCeutical – Filing of Preliminary Prospectus for Initial Public Offering – October 5, 2016

PreveCeutical – Appointment of Shabira Rajan CPA-CGA as Chief Financial Officer – September 6, 2016

PreveCeutical – Appointment of Dr. Makarand Jawadekar as Chief Science Officer – August 16, 2016

PreveCeutical – AGM – Greg S. Ried & Alex Bayer for Election as Directors – August 2, 2016

PreveCeutical – New Website and Corporate Logo – July 11, 2016

PreveCeutical – Public Listing Update – June 27, 2016

PreveCeutical – Attending Secret Knock at San Diego, California – June 16, 2016

PreveCeutical – Attending Cancer Moonshot Summit at Washinton, DC – June 9, 2016

PreveCeutical – Announcing Launch of CELLB9TM – June 1, 2016

Media

CAPITAL STRUCTURE

 
Share Structure as of August 09, 2017

Issued & Outstanding 49,006,275
Securities Reserved for Issuance 9,110,867

Get all the latest news and information about
PreveCeutical Medical Inc.



Input this code: captcha